U.S. markets open in 3 hours 44 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5500+0.2300 (+9.91%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
1,344
2,296
4,507
0
0
Operating Expense
74,971
85,230
129,544
115,252
93,922
Operating Income
-73,627
-82,934
-125,037
-115,252
-93,922
Net Non Operating Interest Income Expense
223
588
2,029
-
-
Other Income Expense
-
4,544
-
-
-
Pretax Income
-70,973
-77,802
-123,008
-115,252
-93,922
Net Income Common Stockholders
-70,973
-77,802
-123,008
-115,561
-93,922
Diluted NI Available to Com Stockholders
-70,973
-77,802
-123,008
-115,561
-93,922
Basic EPS
-
-
-4.49
-4.22
-3.44
Diluted EPS
-
-
-4.49
-4.22
-3.44
Basic Average Shares
-
-
27,380
27,304
27,304
Diluted Average Shares
-
-
27,380
27,304
27,304
Total Operating Income as Reported
-74,071
-81,265
-125,037
-115,252
-93,922
Total Expenses
74,971
85,230
129,544
115,252
93,922
Net Income from Continuing & Discontinued Operation
-70,973
-77,802
-123,008
-115,252
-93,922
Normalized Income
-73,404
-82,346
-123,008
-115,252
-93,922
Interest Income
-
588
2,029
-
-
Net Interest Income
223
588
2,029
-
-
EBIT
-73,627
-82,934
-125,037
-115,252
-93,922
EBITDA
-71,698
-
-
-
-
Reconciled Depreciation
1,929
2,297
2,700
1,528
1,745
Net Income from Continuing Operation Net Minority Interest
-70,973
-77,802
-123,008
-115,252
-93,922
Total Unusual Items Excluding Goodwill
2,431
4,544
-
-
-
Total Unusual Items
2,431
4,544
-
-
-
Normalized EBITDA
-74,129
-85,181
-122,337
-113,724
-92,177
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0